Qvantage™ Hereditary Women's Health Cancer Test, which includes 14 genes predominantly associated with breast, colon, uterine, and ovarian cancers. Qvantage panels, designed for patients with a limited subset of cancers in their family history, only include genes for which national guidelines provide medical management recommendations for pathogenic or likely pathogenic gene variants. In addition, each gene variant detected during testing is interpreted according to a rigorous process led by the company's medical experts.

Cancer:

Breast Cancer, Colon Cancer, Ovarian Cancer, Uterine Cancer

Gene:

ATM (ATM serine/threonine kinase), BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset), CDH1 (Cadherin 1), CHEK2 (Checkpoint kinase 2), EPCAM (Epithelial cell adhesion molecule)

Method:

Next-Generation Sequencing (NGS)

TEST:QVantageᵀᴹ

Details

TEST:
QVantageᵀᴹ